CAT. NO.: AMA-0527
Target Information | |
---|---|
UniProt ID | O60343 |
Product Details | |
---|---|
Size | 100 µL |
Reactivity | Human, Mouse, Rat |
Host | Rabbit |
Source/Isotype | Rabbit IgG |
Storage | Store at -20°C. Do not aliquot the antibody. |
Purification | Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ala195 of human AS160. |
Usage | |
---|---|
Application | WB, IP |
Product Usage Information Dilution | Western Blotting (1:1000); Immunoprecipitation (1:50) |
MW (Target) | 160 kDa |
Background | |
---|---|
Insulin is a major hormone controlling critical energy functions, such as glucose and lipid metabolism. Insulin binds to and activates the insulin receptor (IR) tyrosine kinase, which phosphorylates and recruits adaptor proteins. The signaling pathway initiated by insulin and its receptor stimulates glucose uptake in muscle cells and adipocytes through translocation of the Glut4 glucose transporter from the cytoplasm to the plasma membrane A 160 kDa substrate of the Akt Ser/Thr kinase (AS160, TBC1D4) is a Rab GTPase-activating protein that regulates insulin-stimulated Glut4 trafficking. AS160 is expressed in many tissues including brain, kidney, liver, and brown and white fat Multiple Akt phosphorylation sites have been identified on AS160 in vivo, with five sites (Ser318, Ser570, Ser588, Thr642, and Thr751) showing increased phosphorylation following insulin treatment Studies using recombinant AS160 demonstrate that insulin-stimulated phosphorylation of AS160 is a crucial step in Glut4 translocation and is reduced in some patients with type 2 diabetes The interaction of 14-3-3 regulatory proteins with AS160 phosphorylated at Thr642 is a necessary step for Glut4 translocation Phosphorylation of AS160 by AMPK is involved in the regulation of contraction-stimulated Glut4 translocation. |
Our customers have direct access to our experts and give timely feedback to any online inquiries. If you are interested in our products, please contact us.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.